Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25F2LZV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,815
Award facts
- Contract value 100% obligated
- $4,814.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,814.73 on July 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) to support federal healthcare operations. This firm fixed-price delivery order carries an ultimate completion date of July 8, 2025, and does not utilize a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion master contract vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical product categories supporting Department of Defense medical supply needs.
As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts to distribute branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's primary funding agency is the Medical Supply Chain division within the Department of Defense. This delivery order for Ondansetron ODT, an anti-nausea medication commonly used in healthcare settings, exemplifies the routine pharmaceutical procurement operations executed through the DLA's SPE2DB program to maintain adequate medication inventories across military health facilities.
Quick answers
Who was awarded contract SPE2DX25F2LZV?
SPE2DX25F2LZV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 7, 2025.
How much is contract SPE2DX25F2LZV worth?
The government has obligated $4,815 on SPE2DX25F2LZV.
Is contract SPE2DX25F2LZV an order under another contract?
Yes. SPE2DX25F2LZV is a delivery order under SPE2DX15D9979, an indefinite delivery contract.
Was contract SPE2DX25F2LZV competed?
The extent of competition for SPE2DX25F2LZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award